Deutsch English Français

Contact

EP2916653

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2916653

EP2916653 - ANTIBIOTIC METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 05.10.2018 Database last updated on 30.09.2024
Former	Request for examination was made Status updated on 26.06.2018
Most recent event Tooltip	05.10.2018	Application deemed to be withdrawn	published on 07.11.2018 [2018/45]
Applicant(s)	For all designated states The University of Chicago 5801 South Ellis Avenue Chicago, IL 60637 / US
	[2015/38]
Inventor(s)	01 / DAUM, Robert, S. C/o THE UNIVERSITY OF CHICAGO 5801 S. Ellis Ave. Chicago, IL 60637 / US
	02 / BOYLE-VAVRA, Susan C/o THE UUNIVERSITY OF CHICAGO 5801 S. Ellis Ave. Chicago, IL 60637 / US
	[2015/38]
Representative(s)	Bösl, Raphael Konrad Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstraße 4 68163 Mannheim / DE
	[N/P]
Former [2015/38]	Bösl, Raphael Konrad Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstraße 68 81675 München / DE
Application number, filing date	13850898.1	01.11.2013
	[2015/38]
	WO2013US68085
Priority number, date	US201261721310P	01.11.2012 Original published format: US 201261721310 P
	[2015/38]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014071198
	Date:	08.05.2014
	Language:	EN
	[2014/19]
	Type:	A1 Application with search report
	No.:	EP2916653
	Date:	16.09.2015
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 08.05.2014 takes the place of the publication of the European patent application.
	[2015/38]
Search report(s)	International search report - published on:	US	08.05.2014
	(Supplementary) European search report - dispatched on:	EP	28.06.2016
Classification	IPC:	A01N37/18, A01N43/16, A01N63/00, A61K31/496, A61K31/4709, A61P31/04, A61K31/431, A61K31/122, A61K31/138, A61K31/7048	[2016/30]
	CPC:	A61K31/431 (EP,US); A61K31/05 (EP,US); A61K31/122 (EP,US); A61K31/138 (EP,US); A61K31/165 (EP,US); A61K31/381 (EP,US); (+) A61K31/422 (EP,US); A61K31/4709 (EP,US); A61K31/496 (EP,US); A61K31/7048 (EP,US); A61K45/06 (US); A61P31/04 (EP); A61P43/00 (EP) (-)
	C-Set:	A61K31/05, A61K2300/00 (EP,US); A61K31/122, A61K2300/00 (EP,US); A61K31/138, A61K2300/00 (EP,US); A61K31/431, A61K2300/00 (US,EP); (+) A61K31/4709, A61K2300/00 (US,EP); A61K31/496, A61K2300/00 (US,EP); A61K31/7048, A61K2300/00 (US,EP) (-)
	Former IPC [2015/38]	A01N37/18, A01N43/16, A01N63/00, A61K31/497
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/38]
Title	German:	ANTIBIOTISCHE VERFAHREN UND ZUSAMMENSETZUNGEN FÜR BAKTERIENINFEKTIONEN	[2015/38]
	English:	ANTIBIOTIC METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS	[2015/38]
	French:	MÉTHODES ANTIBIOTIQUES ET COMPOSITIONS D'ANTIBIOTIQUE POUR DES INFECTIONS BACTÉRIENNES	[2015/38]
Entry into regional phase	01.06.2015	National basic fee paid
	01.06.2015	Search fee paid
	01.06.2015	Designation fee(s) paid
	01.06.2015	Examination fee paid
Examination procedure	01.06.2015	Examination requested [2015/38]
	20.01.2017	Amendment by applicant (claims and/or description)
	02.06.2018	Application deemed to be withdrawn, date of legal effect [2018/45]
	27.06.2018	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2018/45]
Fees paid	Renewal fee
	10.11.2015	Renewal fee patent year 03
	25.01.2017	Renewal fee patent year 04
	Penalty fee
	Additional fee for renewal fee
	30.11.2016	04 M06 Fee paid on 25.01.2017
	30.11.2017	05 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XP]WO2013103780 (UNIV BOSTON [US]) [XP] 1-3,5,6,8-14 * paragraph [0005] - paragraph [0014] * * paragraphs [0029] , [0051] - [0055] - [0288]; claims 1,22 *;
		[XI]WO2012032360 (HELPERBY THERAPEUTICS LTD [GB], et al) [X] 1-3,5,6,8-14 * page 15, line 19 - line 36; claims 1,7,12,22 * * page 17, line 16 - page 20, line 19 * * page 32, line 6 - page 33, line 2 * [I] 1-14;
		[XY]EP2243482 (POLICHEM SA [LU]) [X] 11-14 * paragraph [0006] - paragraph [0010]; claims 1-10 * [Y] 1-10;
		[XY]EP1149580 (PFIZER PROD INC [US]) [X] 11-14 * paragraphs [0021] , [0079] , [0080] , [0083] * [Y] 1-10
	International search	[A]US2007258996 (MOOKERJEE PRADIP [US], et al);
		[A]US2010234348 (COTTAREL GUILLAUME [US], et al)
		[Y] - ROHNER ET AL., "Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.", ANTIMICROB AGENTS CHEMOTHER, (198912), vol. 33, no. 12, pages 2037 - 2041, XP055262002
		[Y] - "Noroxin (Norfloxacin)", MERCK, (201202), URL: https://web.archive.org/web/20120415000000*/http://www.merck.com/product/usa/pi_circulars/n/noroxin/noroxin_pi.pdf, (20131230), XP008179693
		[Y] - "Oxacillin Injection.", DRUGS.COM., (20120206), URL: https://web.archive.org/web/20120206070325/http://www.drugs.com/pro/oxacillin-injection.html, (20140101), XP055262008
		[Y] - "Nafcillin", DRUGS.COM., (20100328), URL: https://web.archive.org/web/20100328053716/http://www.drugs.com/pro/nafcillin.html, (20140101), XP055262028
		[Y] - BROWN ET AL., "Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.", AM J VET RES.JULY, (199007), vol. 51, no. 7, pages 1065 - 1070, XP008179697
		[A] - BOYLE-VAVRA ET AL., "VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.", ANTIMICROB AGENTS CHEMOTHER, (201301), vol. 57, no. 1, pages 83 - 95, XP055262031 DOI: http://dx.doi.org/10.1128/AAC.01651-12

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p